Web3 VCs in Brussels
9 funds and 39 venture capitalists based in Brussels.
Funds
Bioqube VenturesEst. 2015 · 16 team · 0 investmentsNewton BiocapitalEst. 2016 · 15 team · 0 investmentsSeeder FundEst. 2016 · 4 team · 0 investmentsScaleFund4 team · 0 investmentsEuroclearEst. 1968 · 0 team · 0 investmentsKBC GroupEst. 1998 · 0 team · 0 investmentsKeyrockEst. 2017 · 0 team · 0 investmentsNicolas Priem0 team · 0 investmentsThibaud Elziere0 team · 0 investments
Investors
Roderick VerhelstPartnerBioqube Ventures
Not publicly disclosed on the current official site.Dirk ReynManaging Partner BFF IBioqube Ventures
Not publicly disclosed on the current official site.Geert TackaertFinance DirectorBioqube Ventures
Not publicly disclosed on the current official site.Alexander DemoulinPrincipalBioqube Ventures
Not publicly disclosed on the current official site.Bonnie van WilgenburgVenture PartnerBioqube Ventures
Not publicly disclosed on the current official site.Clément SalquePrincipalBioqube Ventures
Not publicly disclosed on the current official site.Debora DumontCo-founder and Managing PartnerBioqube Ventures
Not publicly disclosed on the current official site.Janine SchuurmanSenior AdvisorBioqube Ventures
Not publicly disclosed on the current official site.Joris De MaeyerEntrepreneur In ResidenceBioqube Ventures
Not publicly disclosed on the current official site.Joris VanderlochtPartner and CSOBioqube Ventures
Not publicly disclosed on the current official site.Nico VandervelpenCo-founder and Managing PartnerBioqube Ventures
Not publicly disclosed on the current official site.Odile RundquistPartner IR & BDBioqube Ventures
Not publicly disclosed on the current official site.Sandy ZweifachSenior AdvisorBioqube Ventures
Not publicly disclosed on the current official site.Sylvie SchrijversSenior Executive Assistant & Office ManagerBioqube Ventures
Not publicly disclosed on the current official site.Tessa CeyssensChief Operating OfficerBioqube Ventures
Not publicly disclosed on the current official site.Tom HeymanExecutive PartnerBioqube Ventures
Not publicly disclosed on the current official site.David Van TieghemPartnerSeeder Fund
€100K-€250K at pre-seed, up to €500K at seed and €1M-€1.5M maximum total per company, as published by Seeder Fund.Digital TechnologySoftwareB2B Software
Eric VandoornePartnerSeeder Fund
€100K-€250K at pre-seed, up to €500K at seed and €1M-€1.5M maximum total per company, as published by Seeder Fund.Digital TechnologySoftwareB2B Software
Pierre-François HellebuyckInvestment TeamSeeder Fund
€100K-€250K at pre-seed, up to €500K at seed and €1M-€1.5M maximum total per company, as published by Seeder Fund.Digital TechnologySoftwareB2B Software
Isabelle TennstedtInvestment TeamSeeder Fund
€100K-€250K at pre-seed, up to €500K at seed and €1M-€1.5M maximum total per company, as published by Seeder Fund.Digital TechnologySoftwareB2B Software
Alain ParthoensChief Executive OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Sadashi SuzukiJapan RepresentativeNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Guy HeynenChief Medical and Regulatory OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Michihiko WadaChief Regulatory and Development OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Danny GonnissenChief Operating OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Pierre DetrixheVenture DirectorNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Tomoko AsaokaPartnerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Dario PadovaniChief Financial OfficerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Daisuke MorishitaVenture PartnerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Toko SennaAssistant to the CEO / Office ManagerNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Ajit ShettyChairman of the Board of NBC I and NBC IINewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Dirk BoogmansVice-Chairman and Chairman of the Audit Committee of NBC I and NBC IINewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Jean CombalbertIndependent DirectorNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Jean-Claude DeschampsChairman Emeritus and Advisor to the Board of NBC I and NBC IINewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Goro TakedaFounderNewton Biocapital
Newton Biocapital does not publish a standard current check-size range on its official site.BiotechnologyLife SciencesTherapeutics
Claire MunckFounder & Managing Partner ScaleFund I, II & IIIScaleFund
€100K-€1M, as published by ScaleFund.Enterprise SoftwareDeep TechClimate Tech
Gauthier van der ElstPartner ScaleFund I, II & IIIScaleFund
€100K-€1M, as published by ScaleFund.Enterprise SoftwareDeep TechClimate Tech
Thomas PavPrincipal ScaleFund IIIScaleFund
€100K-€1M, as published by ScaleFund.Enterprise SoftwareDeep TechClimate Tech
Paul RisopoulosPrincipal ScaleFund IIIScaleFund
€100K-€1M, as published by ScaleFund.Enterprise SoftwareDeep TechClimate Tech